Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense (Q38285397)

1 September 2017

1 reference

title

Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense (English)

1 reference

1 September 2017

1 reference

Stephan von Gunten

4

0 references

author name string

Kayluz Frias Boligan

series ordinal

1

1 reference

PubMed ID

25487607

1 September 2017

Circe Mesa

series ordinal

2

1 reference

PubMed ID

25487607

1 September 2017

Luis Enrique Fernandez

series ordinal

3

1 reference

1 September 2017

7 December 2014

1 reference

Cellular and Molecular Life Sciences

1 September 2017

1 reference

1 September 2017

72

1 reference

1 September 2017

7

1 reference

1 September 2017

1231-1248

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-014-1799-5

1 September 2017

0 references

cites work

Glycomics hits the big time

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Glycosylation diseases: quo vadis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Nothing in glycobiology makes sense, except in the light of evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Evolutionary considerations in relating oligosaccharide diversity to biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Glycomic analysis of human mast cells, eosinophils and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Glycosylation in cellular mechanisms of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Altered tumor-cell glycosylation promotes metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

The sweet and sour of cancer: glycans as novel therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Microbial glycan microarrays define key features of host-microbial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Phylogenetic analysis of the vertebrate galectin family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Galectins as modulators of tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Since there are PAMPs and DAMPs, there must be SAMPs? Glycan “self-associated molecular patterns” dampen innate immunity, but pathogens can mimic them

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Immunology: glyco-engineering 'super-self'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Tumor-Associated Carbohydrate Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Glycans in cancer and inflammation--potential for therapeutics and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Mucins in cancer: protection and control of the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Molecular recognition of gangliosides and their potential for cancer immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Mucins in cancer: function, prognosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

The sialome--far more than the sum of its parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Suppression of tumor growth and metastasis in Mgat5-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Functional roles of N-glycans in cell signaling and cell adhesion in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Addition of 1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Cell surface glycan-lectin interactions in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

The bisecting GlcNAc in cell growth control and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

ABO blood-group antigens in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Sialic acids sweeten a tumor's life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Sialidase significance for cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

The Biosynthesis of N-Glycoloylneuraminic Acid Occurs by Hydroxylation of the CMP-Glycoside of N-Acetylneuraminic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Detection of CMP-N-acetylneuraminic acid hydroxylase activity in fractionated mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

N-Glycolylneuraminic acid in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Altered sphingolipid metabolism induced by tumor hypoxia - new vistas in glycolipid tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Glycans in immune recognition and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Mammalian glycosylation in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Protein-glycan interactions in the control of innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Signalling through C-type lectin receptors: shaping immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Basic and clinical immunology of Siglecs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

P-selectin deficiency attenuates tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

P-selectin mediates metastatic progression through binding to sulfatides on tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Dendritic cells: a spot on sialic Acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Sialic acid 9-O-acetylation on murine erythroleukemia cells affects complement activation, binding to I-type lectins, and tissue homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Siglecs and their roles in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Siglecs as positive and negative regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Targeting siglecs--a novel pharmacological strategy for immuno- and glycotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Siglec-mediated regulation of immune cell function in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Different patterns of Siglec-9-mediated neutrophil death responses in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Autophagic-like cell death in neutrophils induced by autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Cell death modulation by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Cell death in immune thrombocytopenia: novel insights and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Down-modulation of B cell signal transduction by ligation of mucins to CD22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Siglecs as targets for therapy in immune-cell-mediated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Selectins promote tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Lysosomal targeting of P-selectin is mediated by a novel sequence within its cytoplasmic tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Sulfated glycans control lymphocyte homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Are selectins involved in metastasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Metastatic growth progression caused by PSGL-1-mediated recruitment of monocytes to metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Selectins mediate small cell lung cancer systemic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Carbohydrate to carbohydrate interaction in development process and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

NGcGM3 ganglioside: a privileged target for cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Carbohydrate-mimetic peptides for pan anti-tumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Anti-metastatic effect of the sialyl Lewis-X analog GSC-150 on the human colon carcinoma derived cell line KM12-HX in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Loss of red cell A, B, and H antigens is frequent in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Tumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Gangliosides as immunomodulators

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

21 January 2018

12 December 2020

Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1799-5

Intravenous immunoglobulin preparations contain anti–Siglec-8 autoantibodies

21 January 2018

1 reference

12 December 2020

Biological information transfer beyond the genetic code: the sugar code

1 reference

12 December 2020

Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations

1 reference

12 December 2020

Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status

1 reference

12 December 2020

Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides

1 reference

12 December 2020

Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes

1 reference

12 December 2020

Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer

1 reference

12 December 2020

Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer

1 reference

12 December 2020

Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer

1 reference

12 December 2020

Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker

1 reference

12 December 2020

The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid

1 reference

12 December 2020

Involvement of a non-human sialic Acid in human cancer

1 reference

12 December 2020

Granulocyte Death Regulation by Naturally Occurring Autoantibodies

1 reference

12 December 2020

A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients

1 reference

12 December 2020

Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients

1 reference

12 December 2020

Lysis of tumor cells by natural killer cells in mice is impeded by platelets

1 reference

12 December 2020

Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytes

1 reference

12 December 2020

Gangliosides expressed in human breast cancer

1 reference

12 December 2020

Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool

1 reference

12 December 2020

Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen

1 reference

12 December 2020

10.1007/S00018-014-1799-5

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25487607